首页> 外国专利> POSITIVELY CHARGED WATER-SOLUBLE PRODRUGS OF N-ARYLANTHRANILIC ACIDS WITH VERY FAST SKIN PENETRATION RATE

POSITIVELY CHARGED WATER-SOLUBLE PRODRUGS OF N-ARYLANTHRANILIC ACIDS WITH VERY FAST SKIN PENETRATION RATE

机译:极快的皮肤穿透率的正丙酸正电荷型水溶性产物

摘要

The novel positively charged pro-drugs of arylanthranilic acids in the general formula (1) 'Structure 1' were designed and synthesized. The compounds of the general formula (1) 'Structure 1' indicated above can be prepared from mefenamic acid, meclofenamic acid, flufenamic acid, niflumic acid, flunixin, and related compounds, by reaction with suitable alcohols, thiols, or amines and coupling reagents, such as N, N'-Dicyclohexylcarbodiimide, N, N'-Diisopropylcarbodiimide, O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate, O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate, Benzotriazol-1-yl-oxy-tris (dimethylamino)phosphonium hexafluorophosphate, et al. The positively charged amino groups of these pro-drugs not only largely increases the solubility of the drugs, but also bonds to the negative charge on the phosphate head group of membranes and pushes the pro-drug into the cytosol. The results suggest that the pro-drugs diffuses through human skin -200 times faster than does mefenamic acid, meclofenamic acid, flufenamic acid, niflumic acid, flunixin, and related compounds. It takes 2-4 hours for mefenamic acid, meclofenamic acid, flufenamic acid, niflumic acid, flunixin, and related compounds to reach the peak plasma level when they are taken orally, but these prodrugs only took about -50 minutes to reach the peak plasma level when they are taken transdermally. In plasma, more than 90% of these pro-drugs can change back to the parent drugs in a few minutes. The prodrugs can be used medicinally in treating any NSAIAs-treatable conditions in humans or animals. The prodrugs can be administered not only orally, but also transdermally for any kind of medical treatments and thus avoid most of the side effects of NSAIAs, most notably GI disturbances such as dyspepsia, gastroduodenal bleeding, gastric ulcerations, and gastritis. Controlled transdermal administration systems of the prodrug enables mefenamic acid, meclofenamic acid, flufenamic acid, niflumic acid, flunixin, and related compounds to reach constantly optimal therapeutic blood levels to increase effectiveness and reduce the side effects of mefenamic acid, meclofenamic acid, flufenamic acid, niflumic acid, flunixin, and related compounds. Another great benefit of transdermal administration of these pro-drugs is that administering medication, especially to children, will be much easier.
机译:设计并合成了通式(1)“结构1”中的芳基邻氨基苯甲酸新型带正电荷的前药。上面指出的通式(1)“结构1”的化合物可以通过与合适的醇,硫醇或胺和偶联剂反应,从甲芬那酸,甲氯芬那酸,氟芬那酸,尼氟酸,氟尼辛和相关化合物制得如N,N'-二环己基碳二亚胺,N,N'-二异丙基碳二亚胺,O-(苯并三唑-1-基)-N,N,N',N'-四甲基tetra四氟硼酸酯,O-(苯并三唑-1-基)- N,N,N′,N′-四甲基uro六氟磷酸盐,苯并三唑-1-基-氧-三(二甲氨基)phosph六氟磷酸盐,等。这些前药的带正电荷的氨基基团不仅大大增加了药物的溶解度,而且还与膜的磷酸盐头基团上的负电荷键合并将前药推入细胞质。结果表明,前药在人皮肤中的扩散速度是甲芬那酸,甲氯芬那酸,氟苯那酸,尼氟酸,氟尼辛和相关化合物的200倍。口服时,甲芬那酸,甲氯芬那酸,氟苯那酸,尼氟酸,氟尼辛和相关化合物需要2-4小时达到血浆峰值水平,但这些前药仅需约-50分钟即可达到血浆峰值。透皮服用时的水平。在血浆中,超过90%的这些前药可以在几分钟内变回母体药物。前药可用于治疗人或动物的任何NSAIA可治疗的疾病。前药不仅可以口服,而且可以透皮给药用于任何类型的药物治疗,从而避免了NSAIAs的大多数副作用,尤其是胃肠道疾病,如消化不良,胃十二指肠出血,胃溃疡和胃炎。前药的可控透皮给药系统可使甲芬那酸,甲氯芬那酸,氟芬那酸,尼氟酸,氟尼辛和相关化合物不断达到最佳的治疗血药水平,从而提高疗效并减少甲芬那酸,甲氯芬那酸,氟芬那酸的副作用,尼氟酸,氟尼辛和相关化合物。这些前药的透皮给药的另一大好处是,尤其是对儿童给药更容易。

著录项

  • 公开/公告号PL2084132T3

    专利类型

  • 公开/公告日2019-03-29

    原文格式PDF

  • 申请/专利权人 TECHFIELDS BIOCHEM CO. LTD;YU CHONGXI;

    申请/专利号PL19930067958T

  • 发明设计人 YU CHONGXI;XU LINA;

    申请日2006-09-03

  • 分类号C07D213/74;A61K31/245;A61K31/44;A61P29;C07C237/34;C07C327/30;C07D213/80;

  • 国家 PL

  • 入库时间 2022-08-21 12:01:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号